your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Frequency of adverse effects from RBC transfusion placed in context relative to the risks of other hazards
Frequency of adverse effects from RBC transfusion placed in context relative to the risks of other hazards
Risk is depicted on a logarithmic scale. Shaded bars represent the risk of the adverse event per RBC unit transfused, and unshaded bars represent the risk for fatality per person per year for various life events. Refer to the source document for additional details of these risk calculations. More recent data about flight safety are available at https://www.bts.gov/content/us-air-carrier-safety-data; these suggest that the risk of death from airline crashes is lower than depicted here. Refer to UpToDate for discussions of factors that impact these transfusion-associated risks, and our approaches to evaluating their presence, reducing their frequency, and treating them when they occur.
RBC: red blood cell; HIV: human immunodeficiency virus; HCV: hepatitis C virus; HBV: hepatitis B virus; TRALI: transfusion-related acute lung injury; TACO: transfusion-associated circulatory overload.
References:
Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50:1495.
Zou S, Stramer SL, Notari EP, et al. Current incidence and risk of hepatitis B infection among blood donors in the United States. Transfusion 2009; 49:1609.
Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: Incidence and risk factors. Blood 2012; 119:1757.
US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. US Department of Health and Human Services, Office of the Assistant Secretary for Health, Washington, DC 2011.
Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group. Transfus Med 1994; 4:251.
Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010; 304:1568.
Murphy MF, Wallington TB, Kelsey P, et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113:24.
National Health and Medical Research Council/Australasian Society of Blood Transfusion. Clinical practice guidelines: Appropriate use of red blood cells. National Health and Medical Research Council/Australasian Society of Blood Transfusion, Sydney 2001.
Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51:338.
Popovsky MA, Audet AM, Andrzejewski C Jr. Transfusion-associated circulatory overload in orthopedic surgery patients: A multi-institutional study. Immunohematology 1996; 12:87.
Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2.
Linden JV, Tourault MA, Scribner CL. Decrease in frequency of transfusion fatalities. Transfusion 1997; 37:243.
Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: An analysis of 10 years' experience. Transfusion 2000; 40:1207.
US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: Annual summary for fiscal year 2010. US Food and Drug Administration, Silver Spring, MD 2011.
Federowicz I, Barrett BB, Andersen JW, et al. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996; 36:21.
Kohn L. To err is human: An interview with the Institute of Medicine's Linda Kohn. Jt Comm J Qual Improv 2000; 26:227.
Minino AM, Murphy SL, Xu J, Kochanek, KD. Deaths: Final data for 2008. National Center for Health Statistics, Hyattsville, MD 2011.
